ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Taltirelin hydrate
C17H31N7O9
477.5 g/mol
API

Taltirelin hydrate

CAS201677-75-0
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Taltirelin hydrate is a synthetic analog of thyrotropin-releasing hormone (TRH) with a prolonged duration of action and reduced tolerance development. It is primarily studied for its nootropic, neuroprotective, and analgesic properties.

research compound in neurobiologypharmaceutical raw material for TRH analog development

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Taltirelin hydrate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.74

Thyrotropin-releasing hormone

CAS24305-27-9

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.74

Acetic acid;N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

CAS120876-23-5

research compound

ReferenceSame Category

Tenofovir disoproxil fumarate

CAS202138-50-9

pharmaceutical raw material

ReferenceSame Category

Bilastine

CAS202189-78-4

pharmaceutical raw material

ReferenceSame Category

5-fluorocytosine

CAS2022-85-7

pharmaceutical raw material

ReferenceSame Category

3'-deamino-3'',4'-anhydro-(2''(S)-methoxy-3''(R)-oxy-4''-morpholinyl)doxorubicin

CAS202350-68-3

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide;tetrahydrate

InChIKey

HRCJDWMUKPHPHR-NTFWNTCYSA-N

SMILES

CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N.O.O.O.O

Synonyms (12)
  • Ceredist
  • Ceredist (TN)
  • Taltirelin hydrate
  • Taltirelin hydrate (JP18)
  • Taltirelin tetrahydrate

Sourcing Taltirelin hydrate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→